StockpollyBeta
Get App
Delisting riskPopularity #4,865
ALZN · NASDAQ · Biotechnology

Alzamend Neuro (ALZN)

Develops AL001 and ALZN002 candidates for Alzheimer’s disease and psychiatric disorders.

$1.94
vs last close−0.00 (−0.26%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions17.93%682.2K shares
13 holders · as of Mar 31, 2026
Insiders3.14%119.3K shares
3 holders · as of Aug 31, 2026
Other78.93%3.00M shares
remainder

3.80M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (4.83M in the company's Sep 23, 2026 report, 3.80M elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Kingsbury Capital Investment Advisors LLCInstitution
14.90%566,733as of Mar 31, 2026
Milton C. Iii Ault1Insiderdirector
3.12%118,648filed Aug 31, 2026
Geode Capital Management, LLCInstitution
1.20%45,680as of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.55%21,020as of Mar 31, 2026
Morgan StanleyInstitution
0.47%18,000as of Mar 31, 2026
Clearstead Advisors, LLCInstitution
0.26%10,000as of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution
0.16%6,184as of Mar 31, 2026
Citigroup IncInstitution
0.14%5,231as of Mar 31, 2026
UBS Group AGInstitution
0.12%4,504as of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.12%4,400as of Mar 31, 2026
David J. KatzoffInsiderofficer: Chief Financial Officer
0.02%616filed Mar 24, 2025
BlackRock, Inc.Institution
0.01%437as of Mar 31, 2026
Lynne Fahey McGrathInsiderdirector
0.00%25filed Oct 24, 2025
Sbi Securities Co., Ltd.Institution
0.00%22as of Mar 31, 2026
Caitong International Asset Management Co., LtdInstitution
0.00%4as of Mar 31, 2026
Harbor Investment Advisory, LLCInstitution
0.00%1as of Mar 31, 2026
William B. HorneInsiderdirector
0.00%0filed Dec 23, 2025
Jeffrey Oram2Insiderdirector
0.00%74filed Mar 16, 2022
Mark Gustafson3Insiderdirector
0.00%44filed Apr 4, 2022
Andrew H. Woo4Insiderdirector
0.00%37filed Oct 18, 2021
Stephan Jackman5Insiderdirector, officer: Chief Executive Officer
0.00%34filed May 2, 2023
  1. Reported at 4.40% on Oct 7, 2025, under the 5% line, so no further filing is required.
  2. Last filed Mar 16, 2022; leaving the company requires no filing. Not in the bar.
  3. Last filed Apr 4, 2022; leaving the company requires no filing. Not in the bar.
  4. Last filed Oct 18, 2021; leaving the company requires no filing. Not in the bar.
  5. Last filed May 2, 2023; leaving the company requires no filing. Not in the bar.

13F, as of Mar 31, 2026

13 holders · 682.2K shares · 5 new positions · 7 increased · 1 reduced · 5 closed

HolderShares% outstandingChg q/qFiled
Kingsbury Capital Investment Advisors LLC566.7K14.90%+566.7KnewAug 25, 2026
Geode Capital Management, LLC45.7K1.20%+18.2KMay 15, 2026
Vanguard Fiduciary Trust Co21.0K0.55%+21.0KnewMay 8, 2026
Morgan Stanley18.0K0.47%0May 15, 2026
Clearstead Advisors, LLC10.0K0.26%0May 6, 2026
Tower Research Capital LLC (TRC)6.2K0.16%+4.1KMay 15, 2026
Citigroup Inc5.2K0.14%+5.2KMay 11, 2026
UBS Group AG4.5K0.12%−20.1KMay 5, 2026

13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 14, 2026
Milton C. Iii Aultdirector
Purchase · 2 lots110,388$1.01118,648
Aug 26, 2026
Milton C. Iii Aultdirector
Sale2,000$1.560
Dec 23, 2025
Milton C. Iii Aultdirector
Sale1,851$2.070
Dec 19, 2025
William B. Hornedirector
Sale3,333$2.120
Oct 23, 2025
Lynne Fahey McGrathdirector
Sale30$2.2925
Oct 9, 2025
Milton C. Iii Aultdirector
Sale20,397$2.328,260
Oct 8, 2025
Milton C. Iii Aultdirector
Sale101,394$2.4428,657
Oct 6, 2025
Milton C. Iii Aultdirector
Sale82,033$2.4526,227
Oct 7, 2025
Milton C. Iii Aultdirector
Sale57,379$2.4968,848
Oct 3, 2025
Milton C. Iii Aultdirector
Sale65,903$2.448,260

House and Senate disclosures

Not reported.